Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Spectinomycin (dihydrochloride)

Spectinomycin dihydrochloride is a broad-spectrum antibiotic and inhibits the growth of a variety of gram-positive and gram-negative organisms. Spectinomycin dihydrochloride acts by selectively targeting to the bacterial ribosome and interrupting protein synthesis. Spectinomycin dihydrochloride is also a noncompetitive inhibitor of td intron RNA with an Ki value of 7.2 mM[1]-[5].

Product Specifications

CAS Number

[21736-83-4]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Antibiotic; Bacterial

Type

Natural Products

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/spectinomycin-dihydrochloride.html

Purity

99.73

Solubility

H2O : ≥ 100 mg/mL

Smiles

CN[C@@H]([C@H]([C@@H](NC)[C@@H]1O)O)[C@]2([H])[C@]1([H])O[C@@](O[C@H](C)C3)([H])[C@](O)(C3=O)O2.Cl.Cl

Molecular Formula

C14H26Cl2N2O7

Molecular Weight

405.27

Precautions

H302, H315, H319, H335

References & Citations

[1]Davies J, et al. Inhibition of protein synthesis by spectinomycin. Science. 1965 Sep 3;149 (3688) :1096-8.|[2]Brink MF, et al. Spectinomycin interacts specifically with the residues G1064 and C1192 in 16S rRNA, thereby potentially freezing this molecule into an inactive conformation. Nucleic Acids Res. 1994 Feb 11;22 (3) :325-31. |[3]Park IK, et al. Spectinomycin inhibits the self-splicing of the group 1 intron RNA. Biochem Biophys Res Commun. 2000 Mar 16;269 (2) :574-9. |[4]Khan EA, et al. Safety evaluation study of lincomycin and spectinomycin hydrochloride intramuscular injection in chickens. Toxicol Rep. 2022 Jan 29;9:204-209. |[5]Madhura DB, et al. Pharmacokinetic profile of spectinomycin in rats. Pharmazie. 2013 Aug;68 (8) :675-6.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Natural Products

Clinical Information

Launched

Citation 01

BMC Vet Res. 2022 Jul 12;18 (1) :270.|Patent. US20200368199A1.|Vet Microbiol. 2024 May:292:110046.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Proca1 3'UTR Lenti-reporter-Luc Vector
37728084 1.0 µg

Proca1 3'UTR Lenti-reporter-Luc Vector

Ask
View Details
CLEC12A/MICL/CLL-1 Fc Chimera Protein, Human
UA010272-01 25 µg

CLEC12A/MICL/CLL-1 Fc Chimera Protein, Human

Ask
View Details
CLEC12A/MICL/CLL-1 Fc Chimera Protein, Human
UA010272-02 100 µg

CLEC12A/MICL/CLL-1 Fc Chimera Protein, Human

Ask
View Details
CLEC12A/MICL/CLL-1 Fc Chimera Protein, Human
UA010272-03 500 µg

CLEC12A/MICL/CLL-1 Fc Chimera Protein, Human

Ask
View Details
Human ECE1 Recombinant Protein
PPT-12409 100 µg

Human ECE1 Recombinant Protein

Ask
View Details